Luteal Phase Administration of Paroxetine for the Treatment of PMDD

NCT00620581 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Premenstrual Dysphoric Disorder

Interventions

DRUG: Paroxetine

Sponsor

Hamilton Health Sciences Corporation